logo
logo

Phanes Therapeutics Announces $40 Million Series B Financing

May 25, 2021•over 4 years ago

Amount Raised

$40 Million

Round Type

series b

San Diego

Description

Phanes Therapeutics, Inc. (Phanes), an emerging leader in innovative drug discovery in immuno-oncology, announced today the completion of $40 million Series B financing. The round of financing was led by Sequoia Capital China with participation from new investors and current shareholders. The proceeds from this round will be used to advance several preclinical programs to clinic, expand the research and clinical teams, and support the advancement of research projects in the PACbodyTM and ATACCbodyTM platforms.

Company Information

Company

Phanes

Location

San Diego, California, United States

About

Phanes is a biotech company focused on discovery and development of innovative biologic drugs in oncology and eye diseases. Based in San Diego (USA) and Shanghai (China), the company's management team members previously held senior managerial and R&D positions in leading global pharmaceutical and biotech companies, with tremendous experience in R&D, business development and commercialization. For more information, please visit www.phanesthera.com. SOURCE Phanes Therapeutics

Funding Insights

Based on industry data
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech